SS&C Technologies vs Guidewire
SS&C Technologies vs Guidewire: this page compares business models, financial performance, and market context to help readers understand how the two companies operate. The presentation remains neutral and accessible, focusing on context rather than recommendations. Educational content, not financial advice.
SS&C Technologies vs Guidewire: this page compares business models, financial performance, and market context to help readers understand how the two companies operate. The presentation remains neutral...
Why It's Moving
SS&C Powers Ahead with Q4 Earnings Beat and Strong 2026 Guidance Fueling Analyst Optimism
- Q4 revenue hit $1.65 billion, up 8% year-over-year and beating estimates by 1.8%, highlighting solid execution across its product portfolio.
- Adjusted EPS of $1.69 topped consensus by 5%, with FY2026 guidance at $6.86 midpoint exceeding analyst projections by 3.9%, pointing to sustained profitability.
- Strong cash flow and $0.27 quarterly dividend reinforce shareholder returns, as CEO Bill Stone emphasized record revenues setting up a robust 2026.
SS&C Powers Ahead with Q4 Earnings Beat and Strong 2026 Guidance Fueling Analyst Optimism
- Q4 revenue hit $1.65 billion, up 8% year-over-year and beating estimates by 1.8%, highlighting solid execution across its product portfolio.
- Adjusted EPS of $1.69 topped consensus by 5%, with FY2026 guidance at $6.86 midpoint exceeding analyst projections by 3.9%, pointing to sustained profitability.
- Strong cash flow and $0.27 quarterly dividend reinforce shareholder returns, as CEO Bill Stone emphasized record revenues setting up a robust 2026.
Investment Analysis
Pros
- SS&C Technologies demonstrated strong Q3 2025 results with 7% revenue growth and 17% earnings per share growth, reflecting solid operational execution.
- The company has a diversified technology stack serving financial services and healthcare sectors, reducing dependency on any single market segment.
- Analyst consensus rates SS&C as a strong buy with a forward price target indicating potential upside from current levels.
Considerations
- SS&C's stock exhibits moderate volatility with a Beta of 1.23, indicating higher sensitivity to market swings compared to the broader market.
- While the company pays a dividend, the yield is relatively low at around 1.28%, limiting income appeal to dividend-focused investors.
- Recent short interest increased to over 30%, suggesting elevated bearish sentiment or hedging activity among some investors.
Guidewire
GWRE
Pros
- Guidewire Software benefits from a strong position in the insurance software market, supporting recurring revenue streams from its software platform.
- The company’s growth prospects are driven by ongoing digital transformation trends and demand for cloud-based insurance solutions.
- Guidewire maintains a dedicated R&D focus, enhancing product innovation and long-term competitive advantage in a niche market.
Considerations
- Guidewire is currently considered significantly overvalued by analysts, trading at a large premium compared to intrinsic value estimates.
- The company faces execution risks linked to transitioning customers to cloud models, which can impact near-term margins and growth visibility.
- Macroeconomic uncertainty and competition from larger software vendors increasing pressure on pricing and customer acquisition.
Related Market Insights
Healthcare's Efficiency Crisis: Why Cost-Cutting Stocks Could Surge
Discover why UnitedHealth's cost-cutting signals a surge in healthcare efficiency stocks. Invest in AI & tech solutions driving industry savings.
Aimee Silverwood | Financial Analyst
July 30, 2025
The Unbreakable Bonds: Why These Companies Have Their Customers Trapped
Discover companies with high switching costs, ensuring predictable revenue & pricing power. Invest in indispensable market leaders via Nemo's thematic baskets. Start from $1.
Aimee Silverwood | Financial Analyst
July 25, 2025
Related Market Insights
Healthcare's Efficiency Crisis: Why Cost-Cutting Stocks Could Surge
Discover why UnitedHealth's cost-cutting signals a surge in healthcare efficiency stocks. Invest in AI & tech solutions driving industry savings.
Aimee Silverwood | Financial Analyst
July 30, 2025
The Unbreakable Bonds: Why These Companies Have Their Customers Trapped
Discover companies with high switching costs, ensuring predictable revenue & pricing power. Invest in indispensable market leaders via Nemo's thematic baskets. Start from $1.
Aimee Silverwood | Financial Analyst
July 25, 2025
SS&C Technologies (SSNC) Next Earnings Date
SS&C Technologies (SSNC) is scheduled to report its next earnings on April 23, 2026, covering the first quarter of 2026 ending March 31. This date aligns with analyst projections and the company's historical quarterly reporting pattern following the prior Q4 2025 release on February 5. Investors should monitor official announcements for any adjustments to the schedule or timing.
SS&C Technologies (SSNC) Next Earnings Date
SS&C Technologies (SSNC) is scheduled to report its next earnings on April 23, 2026, covering the first quarter of 2026 ending March 31. This date aligns with analyst projections and the company's historical quarterly reporting pattern following the prior Q4 2025 release on February 5. Investors should monitor official announcements for any adjustments to the schedule or timing.
Which Baskets Do They Appear In?
Healthcare's Efficiency Imperative
UnitedHealth Group's recent profit miss, driven by high medical costs, has triggered a major cost-cutting initiative across the company. This move signals a broader industry trend, creating an investment opportunity in companies that provide AI and technology solutions to help healthcare organizations improve efficiency and reduce operational expenses.
Published: July 30, 2025
Explore BasketHigh-Switching-Cost Traps
These companies provide solutions that become so essential to their customers' operations that leaving is practically impossible. Professional analysts have selected these stocks for their ability to generate reliable revenue thanks to the immense difficulty and expense customers face when considering alternatives.
Published: June 17, 2025
Explore BasketWhich Baskets Do They Appear In?
Healthcare's Efficiency Imperative
UnitedHealth Group's recent profit miss, driven by high medical costs, has triggered a major cost-cutting initiative across the company. This move signals a broader industry trend, creating an investment opportunity in companies that provide AI and technology solutions to help healthcare organizations improve efficiency and reduce operational expenses.
Published: July 30, 2025
Explore BasketHigh-Switching-Cost Traps
These companies provide solutions that become so essential to their customers' operations that leaving is practically impossible. Professional analysts have selected these stocks for their ability to generate reliable revenue thanks to the immense difficulty and expense customers face when considering alternatives.
Published: June 17, 2025
Explore BasketBuy SSNC or GWRE in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Comparisons
SS&C Technologies vs Tyler Technologies
SS&C Technologies vs Tyler Technologies: a neutral, side-by-side comparison of business models, financial metrics, and market context to aid research.
SS&C Technologies vs onsemi
A neutral, educational comparison of SS&C Technologies and onsemi, analysing business models, financials and market context for informed research.
SS&C Technologies vs Twilio
A neutral SS&C Technologies vs Twilio stock comparison covering business models, financial metrics, growth drivers and market context to support informed research.